3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is growing attracting scientific scrutiny due to sparse information suggesting distinct pharmacological actions. Preliminary analyses suggest that 3-HPC may exhibit distinct responses on the nervous structure, potentially influencing to some of the unexpected symptoms related with